Empowered Funds LLC Raises Position in Assertio Holdings, Inc. (NASDAQ:ASRT)

Empowered Funds LLC grew its position in Assertio Holdings, Inc. (NASDAQ:ASRT) by 5.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 455,282 shares of the company’s stock after buying an additional 23,369 shares during the period. Empowered Funds LLC owned approximately 0.48% of Assertio worth $397,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Geode Capital Management LLC raised its holdings in Assertio by 4.1% in the third quarter. Geode Capital Management LLC now owns 1,074,852 shares of the company’s stock worth $1,269,000 after buying an additional 42,750 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its holdings in Assertio by 33.7% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 67,500 shares of the company’s stock worth $59,000 after buying an additional 17,000 shares during the last quarter. Palumbo Wealth Management LLC raised its holdings in Assertio by 9.3% in the third quarter. Palumbo Wealth Management LLC now owns 185,961 shares of the company’s stock worth $219,000 after buying an additional 15,863 shares during the last quarter. Sonora Investment Management Group LLC purchased a new position in Assertio in the fourth quarter worth about $39,000. Finally, GSA Capital Partners LLP purchased a new position in Assertio in the third quarter worth about $177,000. 48.96% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on ASRT shares. StockNews.com upgraded shares of Assertio from a “hold” rating to a “buy” rating in a research note on Wednesday, November 13th. HC Wainwright reiterated a “buy” rating and issued a $4.00 price target on shares of Assertio in a research note on Monday, December 16th.

Assertio Stock Performance

Shares of ASRT stock opened at $0.80 on Thursday. The company has a 50 day moving average price of $0.85 and a 200-day moving average price of $1.01. Assertio Holdings, Inc. has a 52 week low of $0.73 and a 52 week high of $1.80. The firm has a market capitalization of $76.67 million, a PE ratio of -1.10, a P/E/G ratio of 3.37 and a beta of 0.76. The company has a quick ratio of 1.57, a current ratio of 2.01 and a debt-to-equity ratio of 0.30.

About Assertio

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.